Controllo TC a procedura terminata

CASO CLINICO 4: femmina 58 anni, Ca. anaplastico tiroide plurimetastatico. Lesione osteolitica soma L3 trattata con stabilizzazione a due livelli con viti transpeduncolari L1-L5 e barre + laminectomia L3 + decompressione midollare.

Angiografia preoperatoria con embolizzazione arteriosa selettiva del circolo patologico di L3

CASO CLINICO 5: Femmina 44anni, Ca. renale a cellule chiare. Lesione osteolitica in regione metaepifisaria femore sx sottoposta a biopsia TC-guidata e trattata con megaprotesi modulare cementata in seguito ad angiografia preoperatoria con embolizzazione arteriosa selettiva.

RMN preoperatoria sez. coronali in T1, T2 e STIR

CAPITOLO 8

BIBLIOGRAFIA

[1] Incidence, location, and diagnostic evaluation of metastatic bone disease.

Hage WD, Aboulafia AJ, Aboulafia DM. Orthop Clin North Am. 2000 Oct;31(4):515-28, vii.

[2] The perioperative management of skeletal metastases. Bhamra JS, Malik AA, Aresti NA, Khan WS, Pollock RJ Perioper Pract. 2012 Jan;22(1):24-9.

[3] Spinal metastasis in thyroid cancer. Ramadan S, Ugas MA, Berwick RJ,

Notay M, Cho H, Jerjes W, Giannoudis PV. Head Neck Oncol. 2012 Jun 25;4:39. doi: 10.1186/1758-3284-4-39.

[4] Bone metastasis: mechanisms and therapeutic opportunities. Suva LJ,

Washam C, Nicholas RW, Griffin RJ. Nat Rev Endocrinol. 2011 Apr;7(4):208-18. doi: 10.1038/nrendo.2010.227. Epub 2011 Jan 4.

[5] Il trattamento delle metastasi ossee. Piccioli A., Capanna R. Linee Guida S.I.O.T ROSSI srl – Nola - Napoli 2008.

[6] Mechanisms of bone metastasis. Roodman GD. N Engl J Med. 2004 Apr 15;350(16):1655-64.

[7] Clinical features of bone metastases resulting from thyroid cancer: a review of 28 patients over a 20-year period. Do MY, Rhee Y, Kim DJ, Kim CS,

Nam KH, Ahn CW, Cha BS, Kim KR, Lee HC, Park CS, Lim SK. Endocr J. 2005 Dec;52(6):701-7.

[8] A pooled analysis of thyroid cancer studies. V Anthropometric factors. Dal Maso L, La Vecchia C, Franceschi S, Preston-Martin S, Ron E, Levi F, Mack W,

Mark SD, McTiernan A, Kolonel L, Mabuchi K, Jin F, Wingren G, Galanti MR, Hallquist A, Glattre E, Lund E, Linos D, Negri E. Cancer Causes Control 2000;11(2):137-44

[9] Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates. Tickoo SK, Pittas AG, Adler M, Fazzari M, Larson SM, Robbins RJ, Rosai J. Arch Pathol Lab Med. 2000 Oct;124(10):1440-7.

[10] Nuclear medicine in diagnosis, staging and follow-up of thyroid cancer. Mansi L, Moncayo R, CuccurulloV, Dottorini ME, Rimbaldi PF. Q J Nucl Med Mol Imaging 2004;48:82-95.

[11] Patient-specific dosimetry for 131 I thyroid cancer therapy using 124 I PET and 3-dimensional-internal dosimetry (3D-ID) software. Sgouros G, Kolbert KS, Sheikh A, Pentlow KS, Mun EF, Barth A, Robbins RJ, Larson SM. J Nucl Med 2004;45:1366-1372

[12] Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals. Al-Nahhas A. Nucl Med Commun 2004;25:891-895

[13] 18F-FDG PET in insular thyroid cancer. Diehl M, Graichen S, Menzel C, Lindhorst E, Grünwald F. Clin Nucl Med 2003;28:728-731

[14] 18F-FDG PET of patients with Hürthle cell carcinoma. Lowe VJ, Mullan BP, Hay ID, McIver B, Kasperbauer J J Nucl Med 2003;44:1402-1406

extensive conventional radiographic imaging. Sarlis NJ, Gourgiotis L, Guthrie LC, Galen B, Skarulis MC, Shawker TH, Patronas NJ, Reynolds JC Clin Nucl Med 2003;28:208-217

[16] 99m Tc-EDDA/HYNIC-TOC and 18 F-FDG in thyroid cancer patients with negative 131 I whole-body scans. Gabriel M, Froehlich F, Decristoforo C, Ensinger C,Donnemiller E, von Guggenberg E, Heute D, Moncayo R. Eur J Nucl Med Mol Imaging 2004;31:330-341

[17] Rates of malignancy in incidentally discovered thyroid nodules evaluated with sonography and fine-needle aspiration. Liebeskind A, Sikora AG, Komisar A, Slavit D, FriedK. J Ultrasound Med 2005 May;24(5):629-34

[18] Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound. Chammas MC, Gerhard R, de Oliveira IR, Widman A, deBarros N, Durazzo M, Ferraz A, Cerri GG. Otolaryngol Head Neck Surg 2005;132(6):874-82

[19] Sonography and sonographically guided fine-needle aspiration biopsy of the thyroid gland: indications and techniques, pearls and pitfalls. Titton RL, Gervais DA, Boland GW, Maher MM, Mueller PR. Am J Roentgenol 2003;181(1):267-71

[20] Current approaches to primary therapy for papillary and follicular thyroid cancer. Mazzaferri EL, Kloos RT. Journal of Clinical Endocrinology and Metabolism 2001;86:1447-1463

[21] Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, Jamar F, Jarzab

B, Limbert E, Lind P, Reiners C, Franco FS, Smit J, Wiersinga W. European Journal Endocrinology 2005;153:651-659

[22] The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma. Tsang RW, Brierley JD, Simpson WJ, Panzarella T, Gospodarowicz MK, Sutcliffe SB. Cancer 1998;82:375-388

[23] Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F,Jarzab B, Limbert E, Lind P, Pacini F, Reiners C, Sanchez Franco F, Toft A, Wiersinga WM Eur J Endocrinol 2004;15(2):105-112

[24] rhTSH-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Pacini F, Molinaro E, Castagna MG, Agate L, Elisei R, Ceccarelli C, Lippi F, Taddei D, Grasso L, Pinchera A. J Clin Endocrinol Metab 2003;88(8):3668- 3673

[25] The evolving role of 131I for the treatment of differentiated thyroid carcinoma. Robbins RJ, Schlumberger MJ. J Nucl Med 2005;46:28S-37S

[26] Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Taskforce. Cooper DS, Doherty GM, Haugen BR, Kloos T, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Sherman S I, Mtuttle R. Thyroid 2006;16:1-33

Ventroni G, Antonaci A, Vestri AR. Q J Nucl Med Mol Imaging 2004;48:12-19 [28] Lack of impact of radioiodine therapy in thyroglobulin-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancer. Fatourechi V, Hay ID, Javedan H, Wiseman GA, MullanBP, Gorman CA. J Clin Endocrinol Metab 2002;87:1521-1526

[29] Embolization in combination with radioiodine therapy for bone metastases from differentiated thyroid carcinoma. Van Tol KM, Hew JM, Jager PL, Vermey A, Dullaart RP, Links TP. Clin Endocrinol 2002;52:653-65

[30] Related radiofrequency ablation of bony metastatic disease. Posteraro AF, Dupuy DE, Mayo-Smith WW. Clin Radiol 2004;59:803-811

[31] Empirically Treating High Serum Thyroglobulin Levels. Mazzaferri EL.J Nucl Med 2005;46:1079-1088

[32] Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Tokuhashi Y, Matsuzaki H, Toriyama S, Kawano H, Ohsaka S. Spine, 1990; 15:1110-1113

[33] Surgical strategies for spinal metastasis. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H,Akamaru T. Spine, 2001; 26:298-306

[34] The surgical treatment of bony metastases of the spine and limb. Bohm P, Huber J. J Bone Joint Surg, 2002; 84-B:521-9

[35] Prognostic factors and scoring system for patients with skeletal metastasis. Katagiri H, Takahashi M, Wakai K, Sugiura H, Kataoka T, Nakanishi K. J Bone Joint Surg, 2005; 87-B :698-703

Cooperative Oncology Group Scoring Scale and vice-versa. Verger, E., M. Salamero, and C. Conill European Journal of Cancer, 1992. 28A(8-9): p. 1328-1330

[37] Metastatic disease in long bones. Mirels H. Clin Orthop Rel Res. 1989;249:256-264

[38] Percutaneous acetabuloplasty for metastatic acetabular lesions. Maccauro G, Liuzza F, Scaramuzzo L, Milani A, Muratori F, Rossi B, Waide V, Logroscino G, Logroscino CA, Maffulli N. BMC Musculoskelet Disord. 2008 May 5;9:66

[39] Orthopaedic management of extremity and pelvic lesions. Harrington KD. Clin Orthop. 1995;312:136-147

[40] The treatment of metastasis in appendicular skeleton. Capanna R, Campanacci DA. J Bone Joint Surg Br, 2001; 83(4): 471-81